Fig. 1

Kaplan-Meier curves for the cumulative incidence of MACE between MASLD and non-MASLD groups. Statistical significance was determined using the log-rank test MACE, major adverse cardiovascular events; MASLD, metabolic dysfunction-associated steatotic liver disease.